Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Prescription drugs

How Alexion’s Pipeline Is Driving Earnings

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) released its most recent earnings report before the markets opened on Thursday. This company posted $1.26 in earnings per share (EPS) on $831 million in ...
Read Full Story »
Five dollar bill

The Top 5 Earnings Coming Out on Thursday

The most recent earnings season is coming to a close, and the broad markets have been absolutely on the move. The Dow, Nasdaq and S&P 500 have each hit new ...
Read Full Story »
ThinkstockPhotos-475180302

Top 7 Earnings to Look For This Week

24/7 Wall St. has put together a preview of some of the most anticipated quarterly earnings reports expected this coming week. Although earnings season is practically over, the broad markets ...
Read Full Story »
Wow

Major Biotechs Scare Off Loads of Short Sellers

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
biotech word cloud

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, January 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with ...
Read Full Story »
research

Biotech Short Sellers Run for Cover

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
investing

JPMorgan Makes Big Changes to US Analyst Focus List for January

That sure didn't take long. And it probably should come as no surprise that many of the top firms we cover here at 24/7 Wall St. are already tweaking their high ...
Read Full Story »
biotech word cloud

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

As the markets are continuing to heat up a few biotech and pharma companies made massive gains on Thursday. There is a very positive sentiment in the health care sector ...
Read Full Story »
biotech word cloud

Biotech Short Interest Sinks

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
choose happiness

RBC Likes Large Cap Biotech Leaders for 2017

After a very poor 2016 for the biotechs, some on Wall Street are beginning to think that the light at the end of the tunnel may not be another train ...
Read Full Story »
buy sell stocks

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

Wednesday the Dow Jones Industrial Average tried to continue its march to 20,000 but sold off later in the trading session after the Federal Reserve finally raised interest rates for ...
Read Full Story »
Stock Price

Alexion, Ophthotech Don’t Escape Tuesday’s 52-Week Low Club

December 13, 2016: Here are four stocks trading with relatively heavy volume among 41 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

Stocks were mixed on Monday, with the Dow up and the Nasdaq and S&P 500 lower. Those same indexes were indicated higher on Tuesday, and the Dow is getting ever closer ...
Read Full Story »
Stock Price

Ophthotech, Alexion Tumble into Monday’s 52-Week Low Club

December 12, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Monday's session. On the NYSE, decliners led advancers by nearly ...
Read Full Story »
boardroom

Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) saw its shares slide on Monday after the company reported a change in its executive team. Headlining this change and effective immediately, the company announced ...
Read Full Story »